← Company directoryNASDAQ · SEC EDGAR
Tempus AI, Inc.
TEMA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Tempus AI Q3 2026 financial results
Results for the third quarter ended September 30, 2026 will be released before US markets open November 2. Financial performance of data and AI services for precision medicine is in focus.
Tempus AI ↗Tempus AI Q3 2026 earnings call
Management will discuss third-quarter financial results and provide a business update in a conference call and live audio webcast.
Tempus AI ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
TECHBio-Techne CorpNASDAQ · SEC→TECXTectonic Therapeutic, Inc.NASDAQ · SEC→TELATELA Bio, Inc.NASDAQ · SEC→TELOTelomir Pharmaceuticals, Inc.NASDAQ · SEC→TENBTenable Holdings, Inc.NASDAQ · SEC→TENXTenax Therapeutics, Inc.NASDAQ · SEC→TERTeradyne, Inc.NASDAQ · SEC→TFSLTFS Financial CorporationNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.